The ADIPS Pilot National Diabetes in Pregnancy Benchmarking Programme.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
04 05 2021
Historique:
received: 10 03 2021
revised: 18 04 2021
accepted: 30 04 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 22 6 2021
Statut: epublish

Résumé

To test the feasibility of benchmarking the care of women with pregnancies complicated by hyperglycaemia. A retrospective audit of volunteer diabetes services in Australia and New Zealand involving singleton pregnancies resulting in live births between 2014 and 2020. Ranges are shown and compared across services. The audit included 10,144 pregnancies (gestational diabetes mellitus (GDM) = 8696; type 1 diabetes (T1D) = 435; type 2 diabetes (T2D) = 1013) from 11 diabetes services. Among women with GDM, diet alone was used in 39.4% (ranging among centres from 28.8-57.3%), metformin alone in 18.8% (0.4-43.7%), and metformin and insulin in 10.1% (1.5-23.4%); when compared between sites, all Management of maternal hyperglycaemia and pregnancy outcomes varied significantly. The maintenance and extension of this benchmarking service provides opportunities to identify policy and clinical approaches to improve pregnancy outcomes among women with hyperglycaemia in pregnancy.

Sections du résumé

BACKGROUND
To test the feasibility of benchmarking the care of women with pregnancies complicated by hyperglycaemia.
METHODS
A retrospective audit of volunteer diabetes services in Australia and New Zealand involving singleton pregnancies resulting in live births between 2014 and 2020. Ranges are shown and compared across services.
RESULTS
The audit included 10,144 pregnancies (gestational diabetes mellitus (GDM) = 8696; type 1 diabetes (T1D) = 435; type 2 diabetes (T2D) = 1013) from 11 diabetes services. Among women with GDM, diet alone was used in 39.4% (ranging among centres from 28.8-57.3%), metformin alone in 18.8% (0.4-43.7%), and metformin and insulin in 10.1% (1.5-23.4%); when compared between sites, all
CONCLUSION
Management of maternal hyperglycaemia and pregnancy outcomes varied significantly. The maintenance and extension of this benchmarking service provides opportunities to identify policy and clinical approaches to improve pregnancy outcomes among women with hyperglycaemia in pregnancy.

Identifiants

pubmed: 34064492
pii: ijerph18094899
doi: 10.3390/ijerph18094899
pmc: PMC8125192
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

N Engl J Med. 2008 May 8;358(19):1991-2002
pubmed: 18463375
Lancet Diabetes Endocrinol. 2021 Mar;9(3):153-164
pubmed: 33516295
Lancet Diabetes Endocrinol. 2021 Mar;9(3):129-131
pubmed: 33516296
Aust N Z J Obstet Gynaecol. 2020 Dec;60(6):E18-E52
pubmed: 33200400
Aust N Z J Obstet Gynaecol. 2007 Jun;47(3):198-206
pubmed: 17550486
Aust J Rural Health. 2019 Feb;27(1):64-69
pubmed: 30693987
Am J Obstet Gynecol. 1996 Apr;174(4):1343-53
pubmed: 8623868
Diabet Med. 2018 Jul;35(7):929-936
pubmed: 29633347
Med J Aust. 1998 Jul 20;169(2):93-7
pubmed: 9700346
Diabetologia. 2018 May;61(5):1081-1088
pubmed: 29322220
PLoS Med. 2011 Jan 25;8(1):e1000393
pubmed: 21283604
Aust N Z J Obstet Gynaecol. 2020 Oct;60(5):720-728
pubmed: 32157686
Diabetologia. 2017 Sep;60(9):1668-1677
pubmed: 28597075
Aust N Z J Obstet Gynaecol. 2020 Jun;60(3):486-488
pubmed: 32506460
Diabetes Res Clin Pract. 2019 Nov;157:107841
pubmed: 31518656
Diabetes Metab Res Rev. 2015 Oct;31(7):680-90
pubmed: 25663190
PLoS One. 2020 Aug 18;15(8):e0237571
pubmed: 32810195
Diabetes Care. 2005 May;28(5):1260-1
pubmed: 15855607

Auteurs

Jincy Immanuel (J)

School of Medicine, Western Sydney University, 2560 Sydney, Australia.

Jeff Flack (J)

School of Medicine, Western Sydney University, 2560 Sydney, Australia.
Department of Diabetes and Endocrinology, Bankstown-Lidcombe Hospital, 2200 Sydney, Australia.
South Western Sydney Clinical School, University of New South Wales, 2170 Liverpool, Australia.

Vincent W Wong (VW)

South Western Sydney Clinical School, University of New South Wales, 2170 Liverpool, Australia.
Diabetes and Endocrinology Service, Liverpool Hospital, 2170 Sydney, Australia.

Lili Yuen (L)

School of Medicine, Western Sydney University, 2560 Sydney, Australia.

Carl Eagleton (C)

Department of Endocrinology, Auckland City Hospital, 1023 Auckland, New Zealand.

Dorothy Graham (D)

Obstetrics and Gynaecology, King Edward Memorial Hospital, University of Western Australia, 6008 Subiaco, Australia.

Janet Lagstrom (J)

Nathalia Cobram Numurkah Health, 3636 Victoria, Australia.

Louise Wolmarans (L)

Diabetes Service, Waikato Hospital, 3204 Hamilton, New Zealand.

Michele Martin (M)

Diabetes Service, Illawarra Shoalhaven Local Health District, 2500 Wollongong, Australia.

Ngai Wah Cheung (NW)

Department of Diabetes and Endocrinology, Westmead Hospital, 2145 Sydney, Australia.

Suja Padmanabhan (S)

Department of Diabetes and Endocrinology, Westmead Hospital, 2145 Sydney, Australia.

Victoria Rudland (V)

Department of Diabetes and Endocrinology, Westmead Hospital, 2145 Sydney, Australia.

Glynis Ross (G)

Department of Diabetes and Endocrinology, Royal Prince Alfred Hospital, 2050 Sydney, Australia.

Robert G Moses (RG)

Diabetes Service, Illawarra Shoalhaven Local Health District, 2500 Wollongong, Australia.

Louise Maple-Brown (L)

Menzies School of Health Research, Charles Darwin University, 0810 Darwin, Australia.
Department of Endocrinology, Royal Darwin Hospital, 0810 Darwin, Australia.

Ian Fulcher (I)

Department of Obstetrics and Gynaecology, Liverpool Hospital, 2170 Sydney, Australia.

Julie Chemmanam (J)

Endocrinology and Diabetes Centre, Women's and Children's Hospital, 5006 Adelaide, Australia.

Christopher J Nolan (CJ)

Department of Diabetes and Endocrinology, The Canberra Hospital, 2605 Garran, Australia.
Medical School, Australian National University, 2605 Canberra, Australia.

Jeremy J N Oats (JJN)

Melbourne School of Population and Global Health, University of Melbourne, 3053 Victoria, Australia.

Arianne Sweeting (A)

Department of Diabetes and Endocrinology, Royal Prince Alfred Hospital, 2050 Sydney, Australia.

David Simmons (D)

School of Medicine, Western Sydney University, 2560 Sydney, Australia.
Macarthur Diabetes Service, Campbelltown Hospital, 2560 Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH